
Full text loading...
fn1Financial support: This work was supported by UTMB Institute for Human Infections and Immunity seed grant awarded to AGT.
fn2Authors’ addresses: Alfredo G. Torres, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, E-mail: altorres@utmb.edu. Franco E. Montufar, Department of Clinical Pneumology, Universidad de Antioquia, Medellin, Colombia, E-mail: frmontufar@yahoo.com. Jay E. Gee, Alex R. Hoffmaster, and David D. Blaney, Bacterial Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA, E-mails: xzg4@cdc.gov, amh9@cdc.gov, and znr5@cdc.gov. Mindy G. Elrod, Zoonoses and Select Agents, Centers for Disease Control and Prevention, Atlanta, GA, E-mail: wzg0@cdc.gov. Carolina Duarte-Valderrama, Microbiology Group, Instituto Nacional de Salud, Bogota, Colombia, E-mail: cduarte@ins.gov.co. Monica G. Huertas, Department of Microbiology, Universidad El Bosque, Bogota, Colombia, E-mail: mogahuertas@gmail.com.
Disclaimer: The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the aforementioned groups.
Abstract.
Melioidosis, a disease caused by the pathogen Burkholderia pseudomallei, is a significant underreported endemic disease found in tropical countries worldwide. Recent studies have demonstrated that human melioidosis cases have been increasingly recognized in the Americas. Therefore, the first Scientific Reunion of Melioidosis in the Americas was organized in Colombia, with the participation of health authorities of 11 Latin American countries and the United States. This report summarizes the topics reviewed during the meeting, including how to identify human infections and properly diagnose them, with the goal of increasing recognition of the disease in the Americas.